Biocon's FY08 net profit up 12.5 percent, declares 1:1 share bonus

• IBTimes RSS
• Print
• E-Mail
• digg
• Del.icio.us

The earnings per share for the fiscal year ended March 31, 2008, was Rs.22.50 as against Rs.20, a growth of 12.5 percent.

The company does not provide earnings guidance.

However, Mazumdar-Shaw said, "We are on the springboard for a major jump. While in the short term the focus would be on generics and insulin, in the medium term we are looking at bio-similars and the long-term bet is on the drug discovery program," indicating a positive fiscal year ahead.

($1 million = Rs.4 crore)

• 1
• 2